$1.73
-0.23-11.73%
Last update: Oct 16, 6:47 PM
$1.73
-0.23-11.73%
Pacific Biosciences of California Inc
PACBNASDAQ
Pacific Biosciences (PACB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pacific Biosciences (PACB) last issued guidance on August 5, 2026 for fiscal year 2026. The company guided revenue in the range of $155M - $165M for the period.
Compared to prior guidance, Pacific Biosciences lowered its revenue forecast from a prior range of $165M - $175M.
Pacific Biosciences has issued 14 guidance updates between January 9, 2023 and August 5, 2026. During this period, the company raised its outlook 4 times and lowered it 9 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.13 | $-0.14 | $-0.16 | $-0.15 |
| Actual | $-0.14 | $-0.12 | $-0.12 | $-0.12 |
| Surprise | -7.69% | +14.3% | +25.0% | +20.0% |
| Revenue | ||||
| Estimate | $41.0M | $40.2M | $41.8M | $40.1M |
| Actual | $39.0M | $37.2M | $44.6M | $38.4M |
| Surprise | -4.79% | -7.48% | +6.73% | -4.10% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.13 | $-0.12 | $-0.13 |
| Revenue | ||||
| Consensus | $39.1M | $42.8M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.14 | $-0.13 | -7.69 % |
| Q1 | May 7, 2026 | $-0.12 | $-0.14 | 14.3 % |
| Q4 | Feb 12, 2026 | $-0.12 | $-0.16 | 25.0 % |
| Q3 | Nov 5, 2025 | $-0.12 | $-0.15 | 20.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $39.01M | $40.97M | -4.79 % |
| Q1 | May 7, 2026 | $37.18M | $40.18M | -7.48 % |
| Q4 | Feb 12, 2026 | $44.65M | $41.83M | 6.73 % |
| Q3 | Nov 5, 2025 | $38.44M | $40.08M | -4.10 % |
